• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2005-2011 年中国 7 年间志贺菌属分离株的抗菌药物敏感性监测。

Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.

机构信息

Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

出版信息

Ann Lab Med. 2013 Mar;33(2):111-5. doi: 10.3343/alm.2013.33.2.111. Epub 2013 Feb 21.

DOI:10.3343/alm.2013.33.2.111
PMID:23482897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3589635/
Abstract

BACKGROUND

Shigella is a frequent cause of bacterial dysentery in the developing world. Treatment with antibiotics is recommended for shigellosis, but the options are limited due to globally emerging resistance. This study was conducted to determine the frequency and pattern of antimicrobial susceptibility of Shigella in China.

METHODS

We studied the antimicrobial resistance profiles of 308 Shigella spp. strains (260 S. flexneri, 40 S. sonnei, 5 S. boydii, and 3 S. dysenteriae) isolated from fecal samples of patients (age, from 3 months to 92 yr) presenting with diarrhea in different districts of Anhui, China. The antimicrobial resistance of strains was determined by the agar dilution method according to the CSLI guidelines.

RESULTS

The most common serogroup in the Shigella isolates was S. flexneri (n=260, 84.4%), followed by S. sonnei (n=40, 13.0%). The highest resistance rate was found for nalidixic acid (96.4%), followed by ampicillin (93.2%), tetracycline (90.9%), and trimethoprim/sulfamethoxazole (80.8%). Among the isolates tested, 280 (91.0%) were multidrug resistant (resistant to ≥2 agents). The most common resistance pattern was the combination of ampicillin, tetracycline, and trimethoprim/sulfamethoxazole (70.8%). Resistance to ampicillin and tetracycline were more common among S. flexneri than among S. sonnei isolates.

CONCLUSIONS

S. flexneri is predominant in Anhui, China, and its higher antimicrobial resistance rate compared with that of S. sonnei is a cause for concern. Continuous monitoring of resistance patterns is necessary to control the spread of resistance in Shigella. The recommendations for antimicrobial treatment must be updated regularly based on surveillance results.

摘要

背景

志贺菌是发展中国家细菌性痢疾的常见病因。对志贺菌病推荐使用抗生素治疗,但由于全球范围内出现耐药性,选择有限。本研究旨在确定中国志贺菌的抗菌药物敏感性频率和模式。

方法

我们研究了来自中国安徽省不同地区腹泻患者(年龄 3 个月至 92 岁)粪便样本中分离的 308 株志贺菌属(260 株 S. flexneri、40 株 S. sonnei、5 株 S. boydii 和 3 株 S. dysenteriae)的抗菌药物耐药谱。根据 CSLI 指南,采用琼脂稀释法测定菌株的抗菌药物耐药性。

结果

志贺菌分离株中最常见的血清型是 S. flexneri(n=260,84.4%),其次是 S. sonnei(n=40,13.0%)。耐药率最高的是萘啶酸(96.4%),其次是氨苄西林(93.2%)、四环素(90.9%)和甲氧苄啶/磺胺甲噁唑(80.8%)。在所测试的分离株中,280 株(91.0%)为多药耐药(对≥2 种药物耐药)。最常见的耐药模式是氨苄西林、四环素和甲氧苄啶/磺胺甲噁唑的组合(70.8%)。与 S. sonnei 分离株相比,S. flexneri 对氨苄西林和四环素的耐药性更为常见。

结论

S. flexneri 在安徽占优势,其抗菌药物耐药率高于 S. sonnei,令人担忧。需要持续监测耐药模式,以控制志贺菌耐药性的传播。必须根据监测结果定期更新抗菌药物治疗建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a5/3589635/9cd8655f9ff2/alm-33-111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a5/3589635/9cd8655f9ff2/alm-33-111-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8a5/3589635/9cd8655f9ff2/alm-33-111-g001.jpg

相似文献

1
Surveillance of antimicrobial susceptibility patterns among Shigella species isolated in China during the 7-year period of 2005-2011.2005-2011 年中国 7 年间志贺菌属分离株的抗菌药物敏感性监测。
Ann Lab Med. 2013 Mar;33(2):111-5. doi: 10.3343/alm.2013.33.2.111. Epub 2013 Feb 21.
2
Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.卢旺达基加利志贺氏菌分离株的抗微生物耐药性及血清型(1983年至1993年):多重耐药频率增加
Diagn Microbiol Infect Dis. 1997 Aug;28(4):165-71. doi: 10.1016/s0732-8893(97)00072-2.
3
The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.2004 - 2014年中国分离的志贺菌引起的细菌性痢疾流行病学变化及耐药特征
BMC Infect Dis. 2016 Nov 18;16(1):685. doi: 10.1186/s12879-016-1977-1.
4
Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).塞内加尔达喀尔分离的志贺氏菌属中的抗菌素耐药性(2004 - 2006年)
Jpn J Infect Dis. 2008 Jul;61(4):307-9.
5
Drug resistance of Shigella strains isolated in Ankara, Turkey, 1993-1996.1993 - 1996年在土耳其安卡拉分离出的志贺氏菌菌株的耐药性
Scand J Infect Dis. 1998;30(4):351-3. doi: 10.1080/00365549850160620.
6
[Antimicrobial resistance of Shigella spp. in Córdoba, Argentina, during the period 1990-1997].[1990 - 1997年期间阿根廷科尔多瓦地区志贺氏菌属的抗微生物耐药性]
Rev Panam Salud Publica. 2000 Feb;7(2):113-7. doi: 10.1590/s1020-49892000000200007.
7
Shigellosis in Nepal: 13 years review of nationwide surveillance.尼泊尔的志贺氏菌病:全国监测13年回顾
J Health Popul Nutr. 2016 Nov 4;35(1):36. doi: 10.1186/s41043-016-0073-x.
8
Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India.2001年至2004年期间从印度加尔各答住院腹泻儿童中分离出的志贺氏菌属的物种多样性和抗微生物药物耐药性。
Epidemiol Infect. 2005 Dec;133(6):1089-95. doi: 10.1017/S0950268805004498.
9
Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study.美国原住民群体中对甲氧苄啶-磺胺甲恶唑高度耐药的志贺菌的出现:一项流行病学研究。
Am J Epidemiol. 1989 May;129(5):1042-51. doi: 10.1093/oxfordjournals.aje.a115208.
10
Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.1984 - 1989年荷兰分离的志贺氏菌抗生素耐药性监测
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):164-7. doi: 10.1007/BF01967070.

引用本文的文献

1
Molecular epidemiology of extended-spectrum beta-lactamases and carbapenemases-producing Shigella in Africa: a systematic review and meta-analysis.非洲产超广谱β-内酰胺酶和碳青霉烯酶志贺菌的分子流行病学:系统评价与荟萃分析
BMC Infect Dis. 2025 Jan 18;25(1):81. doi: 10.1186/s12879-024-10266-7.
2
Prevalence and changing antimicrobial resistance profiles of Shigella spp. isolated from diarrheal patients in Kolkata during 2011-2019.2011-2019 年从加尔各答腹泻患者中分离的志贺氏菌属的流行情况和不断变化的抗菌药物耐药谱。
PLoS Negl Trop Dis. 2024 Feb 20;18(2):e0011964. doi: 10.1371/journal.pntd.0011964. eCollection 2024 Feb.
3

本文引用的文献

1
Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.1998 年至 2009 年,欧美和亚非地区志贺菌对萘啶酸和环丙沙星的流行率和耐药性变化比较。
Int J Antimicrob Agents. 2012 Jul;40(1):9-17. doi: 10.1016/j.ijantimicag.2012.02.005. Epub 2012 Apr 5.
2
Systemic shigellosis in South Africa.南非的全身性志贺菌病。
Clin Infect Dis. 2012 May;54(10):1448-54. doi: 10.1093/cid/cis224. Epub 2012 Apr 3.
3
Cephalosporin-resistant Shigella flexneri over 9 years (2001-09) in India.
Prevalence of Multidrug-Resistant and Extended-Spectrum Beta-Lactamase-Producing Species in Asia: A Systematic Review and Meta-Analysis.
亚洲产多重耐药和超广谱β-内酰胺酶菌株的流行情况:一项系统评价和荟萃分析
Antibiotics (Basel). 2022 Nov 18;11(11):1653. doi: 10.3390/antibiotics11111653.
4
Changing epidemiology of shigellosis in Taiwan, 2010-2019: an emerging threat to HIV-infected patients and men who have sex with men.2010-2019 年台湾地区志贺菌病的流行情况变化:HIV 感染者和男男性行为者面临的新威胁。
Emerg Microbes Infect. 2022 Dec;11(1):498-506. doi: 10.1080/22221751.2022.2031309.
5
Distribution of genes encoding virulence factors of Shigella strains isolated from children with diarrhea in southwest Iran.伊朗西南部腹泻患儿分离的志贺氏菌菌株毒力因子编码基因的分布。
Mol Biol Rep. 2021 Feb;48(2):1645-1649. doi: 10.1007/s11033-021-06170-x. Epub 2021 Feb 6.
6
Virulence-Related Gene Distribution Among Isolates in Anhui, China: The Association with Antimicrobial Resistance.中国安徽分离株中与毒力相关基因的分布:与抗菌药物耐药性的关联
Infect Drug Resist. 2020 Oct 19;13:3637-3647. doi: 10.2147/IDR.S274862. eCollection 2020.
7
In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant isolates.环丙沙星/磷霉素联合疗法对耐环丙沙星分离株的体外和体内活性
Infect Drug Resist. 2019 Jun 11;12:1619-1628. doi: 10.2147/IDR.S208071. eCollection 2019.
8
Prevalence, associated risk factors and antimicrobial susceptibility patterns of infections among diarrheic pediatric population attending at Gondar town healthcare institutions, Northwest Ethiopia.埃塞俄比亚西北部贡德尔镇医疗机构腹泻儿童人群感染的患病率、相关危险因素及抗菌药物敏感性模式
Trop Dis Travel Med Vaccines. 2019 Apr 18;5:7. doi: 10.1186/s40794-019-0079-7. eCollection 2019.
9
Two novel mutations in among isolated from Jiangsu Province of China, 2016.2016年在中国江苏省分离出的[具体内容]中的两个新突变。 (你提供的原文信息不完整,这里的“Two novel mutations in among ”中第一个“in”后面缺少具体所指内容)
Ann Transl Med. 2018 Aug;6(15):306. doi: 10.21037/atm.2018.07.11.
10
Increasing clinical resistance rate of to cefotaxime in Jiangsu Province, China, between 2012 and 2015.2012年至2015年期间,中国江苏省临床分离菌株对头孢噻肟的耐药率不断上升。
Ann Transl Med. 2018 Jun;6(11):207. doi: 10.21037/atm.2018.05.43.
9 年来(2001-09 年)印度对头孢菌素耐药的福氏志贺菌。
J Antimicrob Chemother. 2012 Jun;67(6):1347-53. doi: 10.1093/jac/dks061. Epub 2012 Mar 12.
4
Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006.2006 年中国河南省人类志贺氏菌感染的流行情况及特征。
J Clin Microbiol. 2011 Jan;49(1):232-42. doi: 10.1128/JCM.01508-10. Epub 2010 Nov 10.
5
Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China.安徽省福氏志贺菌分离株中质粒介导的喹诺酮耐药决定因子的流行情况。
J Antibiot (Tokyo). 2010 Apr;63(4):187-9. doi: 10.1038/ja.2010.16. Epub 2010 Mar 5.
6
Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.中国杭州地区耐氟喹诺酮类福氏志贺菌的特征分析
J Antimicrob Chemother. 2009 May;63(5):917-20. doi: 10.1093/jac/dkp087. Epub 2009 Mar 18.
7
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.一项在六个亚洲国家开展的志贺氏菌腹泻多中心研究:疾病负担、临床表现及微生物学
PLoS Med. 2006 Sep;3(9):e353. doi: 10.1371/journal.pmed.0030353.
8
Trend and disease burden of bacillary dysentery in China (1991-2000).中国细菌性痢疾的流行趋势与疾病负担(1991 - 2000年)
Bull World Health Organ. 2006 Jul;84(7):561-8. doi: 10.2471/blt.05.023853.
9
High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.1999年至2002年期间,美国通过国家抗微生物药物耐药性监测系统检测的志贺氏菌分离株中,抗微生物药物耐药性的高流行率。
Antimicrob Agents Chemother. 2006 Jan;50(1):49-54. doi: 10.1128/AAC.50.1.49-54.2006.
10
Shigellosis : challenges & management issues.志贺氏菌病:挑战与管理问题
Indian J Med Res. 2004 Nov;120(5):454-62.